PLoS ONE (Jan 2014)

An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration.

  • Ashley D Olson,
  • Laurence Meyer,
  • Maria Prins,
  • Rodolphe Thiebaut,
  • Deepti Gurdasani,
  • Marguerite Guiguet,
  • Marie-Laure Chaix,
  • Pauli Amornkul,
  • Abdel Babiker,
  • Manjinder S Sandhu,
  • Kholoud Porter,
  • CASCADE Collaboration in EuroCoord

DOI
https://doi.org/10.1371/journal.pone.0086719
Journal volume & issue
Vol. 9, no. 1
p. e86719

Abstract

Read online

Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype.We assessed a number of EC definitions used in the literature using CASCADE data of 25,692 HIV seroconverters. We estimated proportions maintaining EC of total ART-naïve follow-up time, and disease progression, comparing to non-EC. We also examined HIV-RNA and CD4 values and CD4 slope during EC and beyond (while ART naïve).Most definitions classify ∼ 1% as ECs with median HIV-RNA 43-903 copies/ml and median CD4>500 cells/mm(3). Beyond EC status, median HIV-RNA levels remained low, although often detectable, and CD4 values high but with strong evidence of decline for all definitions. Median % ART-naïve time as EC was ≥ 92% although overlap between definitions was low. EC definitions with consecutive HIV-RNA measurements 90% of measurements <400 copies/ml over ≥ 10 years be used to define this phenotype.